These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3288055)

  • 1. Pathophysiology of cardiomyocytes.
    Borgers M; Ver Donck L; Vandeplassche G
    Ann N Y Acad Sci; 1988; 522():433-53. PubMed ID: 3288055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
    Donck LV; Pauwels PJ; Vandeplassche G; Borgers M
    Life Sci; 1986 Mar; 38(9):765-72. PubMed ID: 3951332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
    Chen M; Xiao CY; Hashizume H; Abiko Y
    Eur J Pharmacol; 1997 Aug; 333(2-3):261-8. PubMed ID: 9314043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lidoflazine and mioflazine against potassium and veratrine induced shape changes in isolated rat cardiac myocytes.
    Ver Donck L; Liu GS; Vandeplassche G; Borgers M
    Basic Res Cardiol; 1987; 82(1):74-81. PubMed ID: 3593184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes.
    Ver Donck L; Verellen G; Vandewiele R; De Clerck F; Borgers M
    Cell Biol Int Rep; 1990 Apr; 14(4):399-406. PubMed ID: 2354524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of calcium antagonists on calcium overload contractures in embryonic chick myocytes induced by ouabain and veratrine.
    Patmore L; Duncan GP; Spedding M
    Br J Pharmacol; 1989 May; 97(1):83-94. PubMed ID: 2470461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+.
    Ravens U; Liu GS; Vandeplassche G; Borgers M
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):47-58. PubMed ID: 1576096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method to study activated oxygen species induced damage in cardiomyocytes and protection by Ca2+-antagonists.
    Ver Donck L; Van Reempts J; Vandeplassche G; Borgers M
    J Mol Cell Cardiol; 1988 Sep; 20(9):811-23. PubMed ID: 3230586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
    Barry WH; Horowitz JD; Smith TW
    Br J Pharmacol; 1985 May; 85(1):51-9. PubMed ID: 4027472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylcholine-induced Ca(2+)-overload in isolated cardiomyocytes and effect of cytoprotective drugs.
    Ver Donck L; Verellen G; Geerts H; Borgers M
    J Mol Cell Cardiol; 1992 Sep; 24(9):977-88. PubMed ID: 1433324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of flunarizine on intracellular calcium in isolated rat cardiomyocytes. A digital image processing study.
    Geerts H; Nuydens R; Nuyens R; Ver Donck L
    Cardiovasc Res; 1989 Sep; 23(9):797-806. PubMed ID: 2611817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM; Wang HX; Xia Q; Wong TM
    Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and mechanisms of action of calcium-channel blockers.
    Katz AM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):28S-37S. PubMed ID: 3540226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of Ca2+ efflux from the heart to the concentration of Ca-channel blockers].
    Khmel'-Dunaĭ GN; Narushiavichus EV
    Biull Eksp Biol Med; 1985 Nov; 100(11):559-61. PubMed ID: 4063502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.